11:01 AM EDT, 04/26/2024 (MT Newswires) -- (Updates to include recent stock movement in the headline and first paragraph.) ResMed ( RMD ) shares rose by more than 17% in recent Friday trading after the company reported fiscal Q3 non-GAAP earnings of $2.13 per diluted share, up from $1.68 a year earlier. Analysts surveyed by Capital IQ expected $1.91. Revenue...

11:02 AM EDT, 04/26/2024 (MT Newswires) -- Kenneth C Kimball, Senior Vice President, on April 25, 2024, sold 30,251 shares in Kroger ( KR ) for $1,693,451. Following the Form 4 filing with the SEC, Kimball has control over a total of 105,298 shares of the company, with 105,298 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/56873/000095017024048737/xslF345X03/ownership.xml Price: 55.48, Change: -0.43, Percent...

11:01 AM EDT, 04/26/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) AppFolio ( APPF ) shares were up more than 16% in recent trading on Friday, a day after the company posted stronger-than-expected Q1 earnings and raised 2024 revenue guidance. The company reported late Thursday it swung to Q1 adjusted earnings of $1.05...

11:00 AM EDT, 04/26/2024 (MT Newswires) -- Amgen ( AMGN ) said Friday it will submit a marketing authorization application to the European Medicines Agency for the teprotumumab medicine to treat moderate to severe thyroid eye disease in adults. Teprotumumab is approved for thyroid eye disease treatment in the US, Brazil and Saudi Arabia under the brand name Tepezza, the...